Sanjeev Kumar Sahu Selected Research

Dengue (Dengue Fever)

12/2022

Emerging quinoline- and quinolone-based antibiotics in the light of epidemics.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sanjeev Kumar Sahu Research Topics

Disease

2	Neoplasms (Cancer) 02/2024 - 01/2023
2	COVID-19 06/2023 - 12/2022
1	Prostatic Neoplasms (Prostate Cancer) 09/2023
1	Carcinoma (Carcinomatosis) 09/2023
1	Malaria 12/2022
1	Communicable Diseases (Infectious Diseases) 12/2022
1	Dengue (Dengue Fever) 12/2022
1	Infections 12/2022
1	Inflammation (Inflammations) 12/2022
1	Respiratory Tract Infections (Respiratory Tract Infection) 12/2022
1	Rupture 12/2022
1	Urinary Tract Infections (Urinary Tract Infection) 12/2022
1	Colorectal Neoplasms (Colorectal Cancer) 12/2022
1	Type 2 Diabetes Mellitus (MODY) 12/2022
1	Gonorrhea 12/2022
1	Diabetes Mellitus 10/2021
1	Acquired Immunodeficiency Syndrome (AIDS) 10/2021
1	Body Weight (Weight, Body) 01/2018

Drug/Important Bio-Agent (IBA)

2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 02/2024 - 12/2022
2	Glucose (Dextrose)FDA LinkGeneric 10/2021 - 01/2018
1	AntioxidantsIBA 03/2024
1	Reactive Oxygen Species (Oxygen Radicals)IBA 02/2024
1	Antineoplastic Agents (Antineoplastics)IBA 02/2024
1	AndrogensIBA 09/2023
1	Angiotensin-Converting Enzyme 2IBA 06/2023
1	IndolesIBA 01/2023
1	Anti-Bacterial Agents (Antibiotics)IBA 12/2022
1	quinolineIBA 12/2022
1	Nucleic AcidsIBA 12/2022
1	QuinolonesIBA 12/2022
1	DNA GyraseIBA 12/2022
1	DNA Topoisomerase IV (Topoisomerase IV)IBA 12/2022
1	EnzymesIBA 12/2022
1	Polysaccharides (Glycans)IBA 10/2021
1	Amylases FDA Link 10/2021
1	MaltoseIBA 10/2021
1	alpha-AmylasesIBA 10/2021
1	CalciumIBA 10/2021
1	Blood Glucose (Blood Sugar)IBA 01/2018
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2018
1	AlloxanIBA 01/2018

Therapy/Procedure

2	Therapeutics 02/2024 - 09/2023